Parkinson’s disease research: adopting a more human perspective to accelerate advances-Reference-Cited by-同舟云学术

Parkinson’s disease research: adopting a more human perspective to accelerate advances

Published:2018-12 Issue:12 Volume:23 Page:1950-1961
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Marshall Lindsay J.^ORCID,Willett Catherine

Funder

PD research

UK-based trial of bilateral infusions of GDNF

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference227 articles.

1. Neurologic Diseases in the Elderly Research Group. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts;De Rijk;Neurology,2000

2. Epidemiology of Parkinson disease;Lee;Neurol Clin.,2016

3. Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC);NIH,2016

4. US Department of Defense, Congressionally Directed Medical Research Programs, 2017, Parkinson’s Research Program Strategic Plan. Retrieved from http://cdmrp.army.mil/prp/pdfs/PRP%20Strategic%20Plan.pdf

5. The Michael J. Fox Foundation for Parkinson’s Research 2015 Annual Report;Michael J. Fox Foundation,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human‐based new approach methodologies to accelerate advances in nutrition research;Food Frontiers;2024-03-05

2. Application of serum peptidomics for Parkinson's disease in SNCA-A30P mice;Heliyon;2023-12

3. Air-liquid interface culture of midbrain organoids improves neuronal functionality and integration of microglia;2023-10-10

4. LINC00943 acts as miR-338-3p sponge to promote MPP+-induced SK-N-SH cell injury by directly targeting SP1 in Parkinson’s disease;Brain Research;2022-05

5. The future of Parkinson’s disease research: A new paradigm of human-specific investigation is necessary… and possible;ALTEX;2022